Lycus Pharma Private Limited - Company Profile

It is a pharma private limited company based in Tiruvalla, Kerala, India, established in 2009.
2009 Tiruvalla, Kerala, India Active
Last Updated:
About Lycus Pharma Private Limited

Lycus Pharma Private Limited, a active private limited company, was established on 06 July 2009 in Tiruvalla, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52311KL2009PTC024412. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Jayan Padmanabhan (Director), Lathish Pulickaparambil Narayanan Nair (Managing Director), Jacob Job (Director). Past directors included Ramesh Kumar Panchayathu Madathil Raveendra Panicker. It holds ₹3.30 M open charges and no settled loans. Its latest AGM occurred on 12 October 2024, with the balance sheet filed on 31 March 2024. It is based at Xiii/331/1, Anjiliveeliyil Building, Near Ymca, Tiruvalla, Kerala, 689101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52311KL2009PTC024412

  • Registration Number

    024412

  • Incorporation Date

    06 July 2009

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.30 M
  • Revenue Growth **** 26.77%
  • Profit Growth **** -14.02%
  • Ebitda **** -2611.72%
  • Net Worth 12.89%
  • Total Assets **** 25.88%
Company report

Lycus Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lycus Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Lycus Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Jayan Padmanabhan Director 30 Mar 2012 Current
Lathish Pulickaparambil Narayanan Nair Managing Director 30 Mar 2012 Current
Jacob Job Director 30 Mar 2012 Current
Jose Joseph Director 06 Jul 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 30 Mar 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lycus Pharma.

Lycus Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.77% increase. The company also saw a substantial fall in profitability, with a 14.02% decrease in profit. The company's net worth Soared by an impressive increase of 12.89%.

Lycus Pharma revenue growth over time
Lycus Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
26.77%
*******
*******
*******
*******
Revenue from Operations
*******
26.77%
*******
*******
*******
*******
Total Assets
*******
25.88%
*******
*******
*******
*******
Profit or Loss
*******
-14.02%
*******
*******
*******
*******
Net Worth
*******
12.89%
*******
*******
*******
*******
EBITDA
*******
-2611.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lycus Pharma?

In 2019, Lycus Pharma had a promoter holding of 18.90% and a public holding of 81.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,300,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.33 Cr
Latest Charge Details
Date Lender Amount Status
09 Feb 2015 Others ₹3.30 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Lycus Pharma?

Unlock and access historical data on people associated with Lycus Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lycus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lycus Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lycus Pharma
Recent Activity within the Organization
  • Charges

    The activity A charge with Others of Rs. 3.30 M registered on 09 Feb 2015 with Charge ID 10549521 was modified on 09 Apr 2025. was completed.

  • Annual General Meeting

    The activity Lycus Pharma Private Limited last Annual general meeting of members was held on 12 Oct 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Lycus Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 3.30 M with Charge ID 10549521 was registered on 09 Feb 2015. was completed.

  • Director Appointment

    Jayan Padmanabhan was appointed as a Director was appointed as a Director on 30 Mar 2012 & has been associated with this company since 13 years 10 months . was recorded as a recent event.

  • Director Appointment

    Progress on Lathish Pulickaparambil Narayanan Nair was appointed as a Managing Director was appointed as a Managing Director on 30 Mar 2012 & has been associated with this company since 13 years 10 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lycus Pharma Private Limited?

The CIN of Lycus Pharma Private Limited is U52311KL2009PTC024412.

Where is Lycus Pharma Private Limited headquartered?

Lycus Pharma Private Limited is headquartered at Xiii/331/1, Anjiliveeliyil Building, Near Ymca, Tiruvalla, Kerala, 689101.

When was Lycus Pharma Private Limited incorporated?

Lycus Pharma Private Limited was incorporated on 06 July 2009.

Who are the current directors of Lycus Pharma Private Limited?

The current directors of Lycus Pharma Private Limited are

What is the primary industry of Lycus Pharma Private Limited?

The primary industry of Lycus Pharma Private Limited is Trade.

Is Lycus Pharma Private Limited a listed company?

Lycus Pharma Private Limited is unlisted.

What is the capital structure of Lycus Pharma Private Limited?

The authorized capital of Lycus Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Lycus Pharma Private Limited?

The compliance status of Lycus Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available